nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—Atrophy—Hydroxyurea—head and neck cancer	0.0402	0.0402	CcSEcCtD
Vigabatrin—Developmental delay—Fluorouracil—head and neck cancer	0.0248	0.0248	CcSEcCtD
Vigabatrin—Congenital anomaly—Fluorouracil—head and neck cancer	0.0248	0.0248	CcSEcCtD
Vigabatrin—Multi-organ failure—Docetaxel—head and neck cancer	0.0209	0.0209	CcSEcCtD
Vigabatrin—Nystagmus—Vinblastine—head and neck cancer	0.0201	0.0201	CcSEcCtD
Vigabatrin—Neurotoxicity—Docetaxel—head and neck cancer	0.0176	0.0176	CcSEcCtD
Vigabatrin—Sensory loss—Vinblastine—head and neck cancer	0.0166	0.0166	CcSEcCtD
Vigabatrin—Encephalopathy—Fluorouracil—head and neck cancer	0.0147	0.0147	CcSEcCtD
Vigabatrin—Nystagmus—Fluorouracil—head and neck cancer	0.0132	0.0132	CcSEcCtD
Vigabatrin—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.0119	0.0119	CcSEcCtD
Vigabatrin—Deafness—Vinblastine—head and neck cancer	0.0117	0.0117	CcSEcCtD
Vigabatrin—Speech disorder—Fluorouracil—head and neck cancer	0.011	0.011	CcSEcCtD
Vigabatrin—Sensory loss—Fluorouracil—head and neck cancer	0.0109	0.0109	CcSEcCtD
Vigabatrin—Disorientation—Hydroxyurea—head and neck cancer	0.0106	0.0106	CcSEcCtD
Vigabatrin—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.0101	0.0101	CcSEcCtD
Vigabatrin—Laryngeal pain—Docetaxel—head and neck cancer	0.00999	0.00999	CcSEcCtD
Vigabatrin—Dysarthria—Fluorouracil—head and neck cancer	0.00997	0.00997	CcSEcCtD
Vigabatrin—Face oedema—Hydroxyurea—head and neck cancer	0.00919	0.00919	CcSEcCtD
Vigabatrin—Scotoma—Docetaxel—head and neck cancer	0.00897	0.00897	CcSEcCtD
Vigabatrin—Otitis media—Docetaxel—head and neck cancer	0.00875	0.00875	CcSEcCtD
Vigabatrin—Oesophagitis—Fluorouracil—head and neck cancer	0.00862	0.00862	CcSEcCtD
Vigabatrin—Breast disorder—Hydroxyurea—head and neck cancer	0.0086	0.0086	CcSEcCtD
Vigabatrin—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00858	0.00858	CcSEcCtD
Vigabatrin—Depression—Vinblastine—head and neck cancer	0.00802	0.00802	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00788	0.00788	CcSEcCtD
Vigabatrin—Disorientation—Fluorouracil—head and neck cancer	0.00766	0.00766	CcSEcCtD
Vigabatrin—Weight increased—Hydroxyurea—head and neck cancer	0.00748	0.00748	CcSEcCtD
Vigabatrin—Drowsiness—Hydroxyurea—head and neck cancer	0.00733	0.00733	CcSEcCtD
Vigabatrin—Infestation NOS—Hydroxyurea—head and neck cancer	0.00733	0.00733	CcSEcCtD
Vigabatrin—Infestation—Hydroxyurea—head and neck cancer	0.00733	0.00733	CcSEcCtD
Vigabatrin—Amnesia—Fluorouracil—head and neck cancer	0.00729	0.00729	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00719	0.00719	CcSEcCtD
Vigabatrin—Hypoaesthesia—Vinblastine—head and neck cancer	0.00718	0.00718	CcSEcCtD
Vigabatrin—Lethargy—Fluorouracil—head and neck cancer	0.00699	0.00699	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.00693	0.00693	CcSEcCtD
Vigabatrin—Respiratory failure—Docetaxel—head and neck cancer	0.00693	0.00693	CcSEcCtD
Vigabatrin—Osteoarthritis—Fluorouracil—head and neck cancer	0.00685	0.00685	CcSEcCtD
Vigabatrin—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00685	0.00685	CcSEcCtD
Vigabatrin—Pulmonary embolism—Docetaxel—head and neck cancer	0.00681	0.00681	CcSEcCtD
Vigabatrin—Hallucination—Hydroxyurea—head and neck cancer	0.00655	0.00655	CcSEcCtD
Vigabatrin—Irritability—Fluorouracil—head and neck cancer	0.00654	0.00654	CcSEcCtD
Vigabatrin—Candida infection—Docetaxel—head and neck cancer	0.0065	0.0065	CcSEcCtD
Vigabatrin—Ataxia—Fluorouracil—head and neck cancer	0.00644	0.00644	CcSEcCtD
Vigabatrin—Oesophagitis—Docetaxel—head and neck cancer	0.00622	0.00622	CcSEcCtD
Vigabatrin—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00612	0.00612	CcSEcCtD
Vigabatrin—Ill-defined disorder—Vinblastine—head and neck cancer	0.00583	0.00583	CcSEcCtD
Vigabatrin—Anaemia—Vinblastine—head and neck cancer	0.00581	0.00581	CcSEcCtD
Vigabatrin—Malaise—Vinblastine—head and neck cancer	0.00567	0.00567	CcSEcCtD
Vigabatrin—Vertigo—Vinblastine—head and neck cancer	0.00565	0.00565	CcSEcCtD
Vigabatrin—Deafness—Docetaxel—head and neck cancer	0.00553	0.00553	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.0055	0.0055	CcSEcCtD
Vigabatrin—Convulsion—Vinblastine—head and neck cancer	0.00544	0.00544	CcSEcCtD
Vigabatrin—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00532	0.00532	CcSEcCtD
Vigabatrin—Pneumonia—Fluorouracil—head and neck cancer	0.00531	0.00531	CcSEcCtD
Vigabatrin—Anaemia—Hydroxyurea—head and neck cancer	0.0053	0.0053	CcSEcCtD
Vigabatrin—Discomfort—Vinblastine—head and neck cancer	0.00529	0.00529	CcSEcCtD
Vigabatrin—Infestation—Fluorouracil—head and neck cancer	0.00528	0.00528	CcSEcCtD
Vigabatrin—Infestation NOS—Fluorouracil—head and neck cancer	0.00528	0.00528	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.00517	0.00517	CcSEcCtD
Vigabatrin—Malaise—Hydroxyurea—head and neck cancer	0.00517	0.00517	CcSEcCtD
Vigabatrin—Conjunctivitis—Fluorouracil—head and neck cancer	0.00513	0.00513	CcSEcCtD
Vigabatrin—Urinary tract infection—Fluorouracil—head and neck cancer	0.00513	0.00513	CcSEcCtD
Vigabatrin—Lethargy—Docetaxel—head and neck cancer	0.00504	0.00504	CcSEcCtD
Vigabatrin—Convulsion—Hydroxyurea—head and neck cancer	0.00496	0.00496	CcSEcCtD
Vigabatrin—Sinusitis—Fluorouracil—head and neck cancer	0.00495	0.00495	CcSEcCtD
Vigabatrin—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.00494	0.00494	CcSEcCtD
Vigabatrin—Pain in extremity—Docetaxel—head and neck cancer	0.00494	0.00494	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00484	0.00484	CcSEcCtD
Vigabatrin—Discomfort—Hydroxyurea—head and neck cancer	0.00482	0.00482	CcSEcCtD
Vigabatrin—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00471	0.00471	CcSEcCtD
Vigabatrin—Oedema—Hydroxyurea—head and neck cancer	0.00468	0.00468	CcSEcCtD
Vigabatrin—Ataxia—Docetaxel—head and neck cancer	0.00465	0.00465	CcSEcCtD
Vigabatrin—Infection—Hydroxyurea—head and neck cancer	0.00465	0.00465	CcSEcCtD
Vigabatrin—Paraesthesia—Vinblastine—head and neck cancer	0.0046	0.0046	CcSEcCtD
Vigabatrin—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00459	0.00459	CcSEcCtD
Vigabatrin—Skin disorder—Hydroxyurea—head and neck cancer	0.00454	0.00454	CcSEcCtD
Vigabatrin—Abdominal pain upper—Docetaxel—head and neck cancer	0.00451	0.00451	CcSEcCtD
Vigabatrin—Breast disorder—Docetaxel—head and neck cancer	0.00447	0.00447	CcSEcCtD
Vigabatrin—Decreased appetite—Vinblastine—head and neck cancer	0.00446	0.00446	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00445	0.00445	CcSEcCtD
Vigabatrin—Nasopharyngitis—Docetaxel—head and neck cancer	0.00442	0.00442	CcSEcCtD
Vigabatrin—Constipation—Vinblastine—head and neck cancer	0.00439	0.00439	CcSEcCtD
Vigabatrin—Pain—Vinblastine—head and neck cancer	0.00439	0.00439	CcSEcCtD
Vigabatrin—Feeling abnormal—Vinblastine—head and neck cancer	0.00423	0.00423	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00419	0.00419	CcSEcCtD
Vigabatrin—Somnolence—Hydroxyurea—head and neck cancer	0.00416	0.00416	CcSEcCtD
Vigabatrin—Dyspepsia—Hydroxyurea—head and neck cancer	0.00412	0.00412	CcSEcCtD
Vigabatrin—Decreased appetite—Hydroxyurea—head and neck cancer	0.00407	0.00407	CcSEcCtD
Vigabatrin—Abdominal pain—Vinblastine—head and neck cancer	0.00405	0.00405	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00404	0.00404	CcSEcCtD
Vigabatrin—Fatigue—Hydroxyurea—head and neck cancer	0.00403	0.00403	CcSEcCtD
Vigabatrin—Constipation—Hydroxyurea—head and neck cancer	0.004	0.004	CcSEcCtD
Vigabatrin—Pain—Hydroxyurea—head and neck cancer	0.004	0.004	CcSEcCtD
Vigabatrin—Weight increased—Docetaxel—head and neck cancer	0.00389	0.00389	CcSEcCtD
Vigabatrin—Vision blurred—Fluorouracil—head and neck cancer	0.00389	0.00389	CcSEcCtD
Vigabatrin—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00385	0.00385	CcSEcCtD
Vigabatrin—Pneumonia—Docetaxel—head and neck cancer	0.00383	0.00383	CcSEcCtD
Vigabatrin—Anaemia—Fluorouracil—head and neck cancer	0.00381	0.00381	CcSEcCtD
Vigabatrin—Infestation NOS—Docetaxel—head and neck cancer	0.00381	0.00381	CcSEcCtD
Vigabatrin—Infestation—Docetaxel—head and neck cancer	0.00381	0.00381	CcSEcCtD
Vigabatrin—Hypersensitivity—Vinblastine—head and neck cancer	0.00378	0.00378	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00378	0.00378	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00373	0.00373	CcSEcCtD
Vigabatrin—Conjunctivitis—Docetaxel—head and neck cancer	0.0037	0.0037	CcSEcCtD
Vigabatrin—Body temperature increased—Hydroxyurea—head and neck cancer	0.0037	0.0037	CcSEcCtD
Vigabatrin—Asthenia—Vinblastine—head and neck cancer	0.00368	0.00368	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Docetaxel—head and neck cancer	0.0036	0.0036	CcSEcCtD
Vigabatrin—Convulsion—Fluorouracil—head and neck cancer	0.00357	0.00357	CcSEcCtD
Vigabatrin—Myalgia—Fluorouracil—head and neck cancer	0.00351	0.00351	CcSEcCtD
Vigabatrin—Chest pain—Fluorouracil—head and neck cancer	0.00351	0.00351	CcSEcCtD
Vigabatrin—Diarrhoea—Vinblastine—head and neck cancer	0.00351	0.00351	CcSEcCtD
Vigabatrin—Discomfort—Fluorouracil—head and neck cancer	0.00347	0.00347	CcSEcCtD
Vigabatrin—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00345	0.00345	CcSEcCtD
Vigabatrin—Hypoaesthesia—Docetaxel—head and neck cancer	0.0034	0.0034	CcSEcCtD
Vigabatrin—Confusional state—Fluorouracil—head and neck cancer	0.00339	0.00339	CcSEcCtD
Vigabatrin—Dizziness—Vinblastine—head and neck cancer	0.00339	0.00339	CcSEcCtD
Vigabatrin—Oedema peripheral—Docetaxel—head and neck cancer	0.00337	0.00337	CcSEcCtD
Vigabatrin—Oedema—Fluorouracil—head and neck cancer	0.00337	0.00337	CcSEcCtD
Vigabatrin—Connective tissue disorder—Docetaxel—head and neck cancer	0.00336	0.00336	CcSEcCtD
Vigabatrin—Asthenia—Hydroxyurea—head and neck cancer	0.00336	0.00336	CcSEcCtD
Vigabatrin—Infection—Fluorouracil—head and neck cancer	0.00334	0.00334	CcSEcCtD
Vigabatrin—Nervous system disorder—Fluorouracil—head and neck cancer	0.0033	0.0033	CcSEcCtD
Vigabatrin—Visual impairment—Docetaxel—head and neck cancer	0.0033	0.0033	CcSEcCtD
Vigabatrin—Vomiting—Vinblastine—head and neck cancer	0.00326	0.00326	CcSEcCtD
Vigabatrin—Erythema multiforme—Docetaxel—head and neck cancer	0.00323	0.00323	CcSEcCtD
Vigabatrin—Headache—Vinblastine—head and neck cancer	0.00321	0.00321	CcSEcCtD
Vigabatrin—Diarrhoea—Hydroxyurea—head and neck cancer	0.0032	0.0032	CcSEcCtD
Vigabatrin—Eye disorder—Docetaxel—head and neck cancer	0.0032	0.0032	CcSEcCtD
Vigabatrin—Dizziness—Hydroxyurea—head and neck cancer	0.00309	0.00309	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00307	0.00307	CcSEcCtD
Vigabatrin—Nausea—Vinblastine—head and neck cancer	0.00305	0.00305	CcSEcCtD
Vigabatrin—Insomnia—Fluorouracil—head and neck cancer	0.00304	0.00304	CcSEcCtD
Vigabatrin—Paraesthesia—Fluorouracil—head and neck cancer	0.00302	0.00302	CcSEcCtD
Vigabatrin—Mental disorder—Docetaxel—head and neck cancer	0.003	0.003	CcSEcCtD
Vigabatrin—Somnolence—Fluorouracil—head and neck cancer	0.00299	0.00299	CcSEcCtD
Vigabatrin—Malnutrition—Docetaxel—head and neck cancer	0.00298	0.00298	CcSEcCtD
Vigabatrin—Vomiting—Hydroxyurea—head and neck cancer	0.00297	0.00297	CcSEcCtD
Vigabatrin—Dyspepsia—Fluorouracil—head and neck cancer	0.00296	0.00296	CcSEcCtD
Vigabatrin—Rash—Hydroxyurea—head and neck cancer	0.00295	0.00295	CcSEcCtD
Vigabatrin—Dermatitis—Hydroxyurea—head and neck cancer	0.00295	0.00295	CcSEcCtD
Vigabatrin—Headache—Hydroxyurea—head and neck cancer	0.00293	0.00293	CcSEcCtD
Vigabatrin—Decreased appetite—Fluorouracil—head and neck cancer	0.00293	0.00293	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.00291	0.00291	CcSEcCtD
Vigabatrin—Back pain—Docetaxel—head and neck cancer	0.00288	0.00288	CcSEcCtD
Vigabatrin—Pain—Fluorouracil—head and neck cancer	0.00288	0.00288	CcSEcCtD
Vigabatrin—Muscle spasms—Docetaxel—head and neck cancer	0.00286	0.00286	CcSEcCtD
Vigabatrin—Nausea—Hydroxyurea—head and neck cancer	0.00278	0.00278	CcSEcCtD
Vigabatrin—Feeling abnormal—Fluorouracil—head and neck cancer	0.00277	0.00277	CcSEcCtD
Vigabatrin—Anaemia—Docetaxel—head and neck cancer	0.00275	0.00275	CcSEcCtD
Vigabatrin—Urticaria—Fluorouracil—head and neck cancer	0.00267	0.00267	CcSEcCtD
Vigabatrin—Body temperature increased—Fluorouracil—head and neck cancer	0.00266	0.00266	CcSEcCtD
Vigabatrin—Cough—Docetaxel—head and neck cancer	0.0026	0.0026	CcSEcCtD
Vigabatrin—Convulsion—Docetaxel—head and neck cancer	0.00258	0.00258	CcSEcCtD
Vigabatrin—Arthralgia—Docetaxel—head and neck cancer	0.00253	0.00253	CcSEcCtD
Vigabatrin—Chest pain—Docetaxel—head and neck cancer	0.00253	0.00253	CcSEcCtD
Vigabatrin—Myalgia—Docetaxel—head and neck cancer	0.00253	0.00253	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.00252	0.00252	CcSEcCtD
Vigabatrin—Hypersensitivity—Fluorouracil—head and neck cancer	0.00248	0.00248	CcSEcCtD
Vigabatrin—Confusional state—Docetaxel—head and neck cancer	0.00245	0.00245	CcSEcCtD
Vigabatrin—Oedema—Docetaxel—head and neck cancer	0.00243	0.00243	CcSEcCtD
Vigabatrin—Infection—Docetaxel—head and neck cancer	0.00241	0.00241	CcSEcCtD
Vigabatrin—Nervous system disorder—Docetaxel—head and neck cancer	0.00238	0.00238	CcSEcCtD
Vigabatrin—Pruritus—Fluorouracil—head and neck cancer	0.00238	0.00238	CcSEcCtD
Vigabatrin—Skin disorder—Docetaxel—head and neck cancer	0.00236	0.00236	CcSEcCtD
Vigabatrin—Diarrhoea—Fluorouracil—head and neck cancer	0.0023	0.0023	CcSEcCtD
Vigabatrin—Dizziness—Fluorouracil—head and neck cancer	0.00223	0.00223	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00221	0.00221	CcSEcCtD
Vigabatrin—Insomnia—Docetaxel—head and neck cancer	0.0022	0.0022	CcSEcCtD
Vigabatrin—Paraesthesia—Docetaxel—head and neck cancer	0.00218	0.00218	CcSEcCtD
Vigabatrin—Somnolence—Docetaxel—head and neck cancer	0.00216	0.00216	CcSEcCtD
Vigabatrin—Vomiting—Fluorouracil—head and neck cancer	0.00214	0.00214	CcSEcCtD
Vigabatrin—Dyspepsia—Docetaxel—head and neck cancer	0.00214	0.00214	CcSEcCtD
Vigabatrin—Rash—Fluorouracil—head and neck cancer	0.00212	0.00212	CcSEcCtD
Vigabatrin—Dermatitis—Fluorouracil—head and neck cancer	0.00212	0.00212	CcSEcCtD
Vigabatrin—Decreased appetite—Docetaxel—head and neck cancer	0.00211	0.00211	CcSEcCtD
Vigabatrin—Headache—Fluorouracil—head and neck cancer	0.00211	0.00211	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.0021	0.0021	CcSEcCtD
Vigabatrin—Fatigue—Docetaxel—head and neck cancer	0.00209	0.00209	CcSEcCtD
Vigabatrin—Constipation—Docetaxel—head and neck cancer	0.00208	0.00208	CcSEcCtD
Vigabatrin—Pain—Docetaxel—head and neck cancer	0.00208	0.00208	CcSEcCtD
Vigabatrin—Feeling abnormal—Docetaxel—head and neck cancer	0.002	0.002	CcSEcCtD
Vigabatrin—Nausea—Fluorouracil—head and neck cancer	0.002	0.002	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Docetaxel—head and neck cancer	0.00199	0.00199	CcSEcCtD
Vigabatrin—Abdominal pain—Docetaxel—head and neck cancer	0.00192	0.00192	CcSEcCtD
Vigabatrin—Body temperature increased—Docetaxel—head and neck cancer	0.00192	0.00192	CcSEcCtD
Vigabatrin—Hypersensitivity—Docetaxel—head and neck cancer	0.00179	0.00179	CcSEcCtD
Vigabatrin—Asthenia—Docetaxel—head and neck cancer	0.00174	0.00174	CcSEcCtD
Vigabatrin—Pruritus—Docetaxel—head and neck cancer	0.00172	0.00172	CcSEcCtD
Vigabatrin—Diarrhoea—Docetaxel—head and neck cancer	0.00166	0.00166	CcSEcCtD
Vigabatrin—Dizziness—Docetaxel—head and neck cancer	0.00161	0.00161	CcSEcCtD
Vigabatrin—Vomiting—Docetaxel—head and neck cancer	0.00154	0.00154	CcSEcCtD
Vigabatrin—Rash—Docetaxel—head and neck cancer	0.00153	0.00153	CcSEcCtD
Vigabatrin—Dermatitis—Docetaxel—head and neck cancer	0.00153	0.00153	CcSEcCtD
Vigabatrin—Headache—Docetaxel—head and neck cancer	0.00152	0.00152	CcSEcCtD
Vigabatrin—Nausea—Docetaxel—head and neck cancer	0.00144	0.00144	CcSEcCtD
